Table 6.

Multivariate analysis of prognostic factors for FFS in 314 patients with cHD treated with ABVD or equivalent regimens who had complete data

Prognostic factorRelative risk (RR) of failure
RR95% CIP6-150
BCL-2+ 3.0 1.6-5.7 .0005  
Age 45 y or older 2.1 1.2-3.8 .01  
Ann Arbor stage IV 2.2 1.3-3.5 .003  
Low serum albumin6-151 2.8 1.7-4.6 <.0001  
High serum LDH6-151 1.9 1.1-3.0 .01 
Prognostic factorRelative risk (RR) of failure
RR95% CIP6-150
BCL-2+ 3.0 1.6-5.7 .0005  
Age 45 y or older 2.1 1.2-3.8 .01  
Ann Arbor stage IV 2.2 1.3-3.5 .003  
Low serum albumin6-151 2.8 1.7-4.6 <.0001  
High serum LDH6-151 1.9 1.1-3.0 .01 
F6-150

Cox proportional hazards model.

F6-151

As defined in “Patients and methods.”

Close Modal

or Create an Account

Close Modal
Close Modal